1049808-01-6Relevant articles and documents
Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements
Ameriks, Michael K.,Axe, Frank U.,Bembenek, Scott D.,Edwards, James P.,Gu, Yin,Karlsson, Lars,Randal, Mike,Sun, Siquan,Thurmond, Robin L.,Zhu, Jian
, p. 6131 - 6134 (2009)
A crystal structure of 1 bound to a Cys25Ser mutant of cathepsin S helped to elucidate the binding mode of a previously disclosed series of pyrazole-based CatS inhibitors and facilitated the design of a new class of arylalkyne analogs. Optimization of the
CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S
-
Page/Page column 28, (2008/12/08)
Carbon-linked tetrahydro-pyrazolo-pyridine compounds are described, which are useful as cathepsin S modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by cathepsin S activity, such as psoriasis, pain, multiple sclerosis, atherosclerosis, and rheumatoid arthritis.